Angiotensin II Activates YAP in Fibroblasts and Promotes Deep Fascia Remodeling (PMID: 41303588)
Research Question
Can a biochemical signal called Angiotensin II (Ang II) influence how deep fascia changes and remodels over time?
This study explored whether Ang II activates Yes-associated protein (YAP)—a key cellular mechanosensor—in human fascial fibroblasts and whether this pathway contributes to tissue remodeling and fibrosis in deep fascia.
Methods
Researchers studied human fibroblasts isolated from deep fascia and investigated how they responded to Ang II exposure.
They examined:
Whether fascial fibroblasts contain Angiotensin II receptors
How Ang II affects YAP activation
Changes in fibrosis-related gene expression
Fibroblast growth and migration behavior
Whether blocking the pathway changes these effects
To test this, they used:
Irbesartan (an AT1 receptor blocker)
Verteporfin (a YAP inhibitor)
Key Findings
The study found that fascial fibroblasts are highly responsive to Ang II signaling.
Main findings included:
Deep fascia fibroblasts contained Angiotensin II receptors, with AT1R being the dominant receptor.
Short exposure to Ang II activated YAP, allowing it to move into the cell nucleus where it can influence gene activity.
Long-term exposure increased the expression of genes linked to fibrotic remodeling, including:
Collagen type I
Collagen type III
Hyaluronan binding protein 2 (HABP2)
Ang II also increased fibroblast proliferation and migration, behaviors commonly associated with tissue remodeling and fibrosis.
Blocking AT1R or inhibiting YAP reduced these remodeling effects.
Why It Matters for Fascia
This research supports the growing understanding that deep fascia behaves like a living, responsive tissue—not simply a passive covering around muscles.
The findings suggest fascia can respond not only to mechanical loading and movement, but also to chemical signaling pathways.
The newly identified Ang II–YAP pathway may help explain how fascial tissues adapt—or become dysfunctional—over time through excessive remodeling and fibrosis.
This could eventually influence research into:
Chronic pain mechanisms
Fascial stiffness and reduced glide
Tissue adaptation and recovery
Future therapeutic approaches targeting fascial remodeling
5 Takeaways
Deep fascia contains active fibroblasts that respond to biochemical signals.
Angiotensin II can activate YAP, an important cellular mechanosensor.
YAP activation may encourage collagen production and tissue remodeling.
Excessive signaling may contribute to fibrosis-like changes in fascia.
Blocking the Ang II–YAP pathway may become an area of future fascia research and therapy.